Vitura Health Ltd
ASX:VIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vitura Health Ltd
ASX:VIT
|
AU |
|
E
|
Equity Development Investment Tbk PT
IDX:GSMF
|
ID |
|
Gayatri BioOrganics Ltd
BSE:524564
|
IN |
|
East West Bancorp Inc
NASDAQ:EWBC
|
US |
|
EDP Renovaveis SA
OTC:EDRVY
|
ES |
|
Relo Group Inc
TSE:8876
|
JP |
|
J
|
Jiangsu Changhai Composite Materials Co Ltd
SZSE:300196
|
CN |
|
Valor Resources Ltd
ASX:VAL
|
AU |
|
K
|
Kunshan Asia Aroma Corp Ltd
SZSE:301220
|
CN |
|
E
|
EA Holdings Bhd
KLSE:EAH
|
MY |
Vitura Health Ltd
Vitura Health Ltd. operates as a medicinal cannabis company. The firm through its wholly owned subsidiary, CDA Health Pty Ltd, operates businesses, such as Burleigh Heads Cannabis and CDA Clinics. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes approximately 200 product stock-keeping units (SKUs) within Australia from 30 international and domestic medicinal cannabis producers. CDA Clinics undertakes telehealth consultations with patients seeking access to medicinal cannabis. Its portfolio of brands includes CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc and Adaya. The firm owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes nationwide telehealth consultations with patients seeking access to medicinal cannabis.
Vitura Health Ltd. operates as a medicinal cannabis company. The firm through its wholly owned subsidiary, CDA Health Pty Ltd, operates businesses, such as Burleigh Heads Cannabis and CDA Clinics. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes approximately 200 product stock-keeping units (SKUs) within Australia from 30 international and domestic medicinal cannabis producers. CDA Clinics undertakes telehealth consultations with patients seeking access to medicinal cannabis. Its portfolio of brands includes CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc and Adaya. The firm owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes nationwide telehealth consultations with patients seeking access to medicinal cannabis.
Revenue Growth: Vitura reported 8% revenue growth for the half, with management calling it a pass mark and expecting higher growth ahead.
Margin Pressure: Gross margins fell from 27% to about 23% due to industry price pressures and increased costs, but management believes the level has now stabilized.
Segment Performance: The Canvue platform saw nearly 11% growth in cannabis distribution, and specialty clinics and Doctors on Demand posted a 25% revenue increase from a low base.
Cost Control: Operating expenses have been reduced by 10% in the past 4 weeks, with $2.8 million in cost savings expected to flow through in coming months.
Leadership Changes: New interim executive appointments and a new CFO are in place, with a CEO search underway.
Outlook: Management expects strong double-digit revenue growth over the next two years, and aims to hold margins and further reduce operating costs.
